Abstract 4711: The PI3K-δ inhibitor TGR-1202 in combination with Brentuximab Vedotin (SGN-35) synergistically induces G2/M phase arrest and cell death via inhibition of tubulin polymerization in Hodgkin lymphoma cell lines

Author(s):  
Silvia L. Locatelli ◽  
Silvia Tartari ◽  
Luca Castagna ◽  
Luca Rubino ◽  
Srikant Viswanadha ◽  
...  
Leukemia ◽  
2016 ◽  
Vol 30 (12) ◽  
pp. 2402-2405 ◽  
Author(s):  
S L Locatelli ◽  
G Careddu ◽  
G Inghirami ◽  
L Castagna ◽  
P Sportelli ◽  
...  

Author(s):  
A Ustaszewski ◽  
J Paczkowska ◽  
J Janiszewska ◽  
S Hartmann ◽  
J Bein ◽  
...  

2010 ◽  
Vol 177 (6) ◽  
pp. 3081-3088 ◽  
Author(s):  
Jun-ichiro Ikeda ◽  
Suhana Mamat ◽  
Tian Tian ◽  
Yi Wang ◽  
Nur Rahadiani ◽  
...  

2011 ◽  
Vol 39 (8) ◽  
pp. 850-858 ◽  
Author(s):  
Ingrid Glimelius ◽  
Jenny Rubin ◽  
Marie Fischer ◽  
Daniel Molin ◽  
Rose-Marie Amini ◽  
...  

2008 ◽  
Vol 122 (4) ◽  
pp. 769-776 ◽  
Author(s):  
Donatella Aldinucci ◽  
Debora Lorenzon ◽  
Lara Cattaruzza ◽  
Antonio Pinto ◽  
Annunziata Gloghini ◽  
...  

2016 ◽  
Vol 12 (1) ◽  
pp. 219-232 ◽  
Author(s):  
D. Vergara ◽  
P. Simeone ◽  
S. De Matteis ◽  
S. Carloni ◽  
P. Lanuti ◽  
...  

Classical Hodgkin lymphoma models of T- and B-cell derivation show significant differences in their protein expression profiles.


Sign in / Sign up

Export Citation Format

Share Document